National Research (NASDAQ:NRC) Stock Passes Above 200 Day Moving Average – What’s Next?

National Research Corporation (NASDAQ:NRC)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $18.13 and traded as high as $22.51. National Research shares last traded at $21.98, with a volume of 96,977 shares changing hands.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on NRC shares. Citizens Jmp started coverage on National Research in a research note on Monday, June 22nd. They issued a “market outperform” rating and a $23.00 price target on the stock. Weiss Ratings upgraded shares of National Research from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 29th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, National Research has an average rating of “Moderate Buy” and a consensus target price of $23.00.

National Research Price Performance

The company has a market cap of $499.13 million, a PE ratio of 56.26 and a beta of 0.35. The stock has a fifty day moving average price of $19.96 and a 200-day moving average price of $18.16. The company has a debt-to-equity ratio of 5.48, a current ratio of 0.52 and a quick ratio of 0.52.

National Research (NASDAQ:NRC) last issued its quarterly earnings results on Tuesday, April 28th. The company reported $0.21 earnings per share for the quarter. The business had revenue of $34.80 million for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.

Hedge Funds Weigh In On National Research

Institutional investors and hedge funds have recently bought and sold shares of the business. Heartland Advisors Inc. increased its holdings in shares of National Research by 374.3% in the 1st quarter. Heartland Advisors Inc. now owns 237,147 shares of the company’s stock valued at $4,027,000 after purchasing an additional 187,147 shares during the period. AQR Capital Management LLC boosted its holdings in shares of National Research by 86.2% during the second quarter. AQR Capital Management LLC now owns 201,396 shares of the company’s stock worth $3,383,000 after purchasing an additional 93,262 shares during the period. Fifth Third Bancorp acquired a new stake in shares of National Research during the first quarter worth approximately $1,531,000. Jane Street Group LLC grew its position in National Research by 394.2% during the first quarter. Jane Street Group LLC now owns 52,411 shares of the company’s stock valued at $671,000 after purchasing an additional 41,806 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its position in National Research by 180.8% during the third quarter. Arrowstreet Capital Limited Partnership now owns 49,076 shares of the company’s stock valued at $627,000 after purchasing an additional 31,599 shares in the last quarter. Hedge funds and other institutional investors own 47.26% of the company’s stock.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.